Skip to content

Investor Relations / Publications / Publications Search

Publications Search

Budoff MJ, Muhlestein JB, Bhatt DL, et al. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: A prospective, placebo-controlled randomized trial (EVAPORATE): Interim Results [published online ahead of print, 2020 Jul 1]. Cardiovasc Res. 2020;cvaa184. doi:10.1093/cvr/cvaa184

https://academic.oup.com/cardiovascres/article-abstract/doi/10.1093/cvr/cvaa184/5865857

American Heart Association
Budoff MJ, Muhlestein JB, Bhatt DL, Le VT, May HT, Shaikh K, Shekar C, Kinninger A, Lakshmanan S, Roy S, Tayek J, Nelson JR. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy (EVAPORATE study) [abstract]. Presented at: Annual Scientific Sessions of the American Heart Association; November 16-18, 2019, 2019; Philadelphia, PA.

https://www.abstractsonline.com/pp8/#!/7891/presentation/35090

Budoff M, Muhlestein JB, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clin Cardiol. 2018;41:13-19.
Free:
http://onlinelibrary.wiley.com/doi/10.1002/clc.22856/full

http://onlinelibrary.wiley.com/doi/10.1002/clc.22856/full

Amarin Corporation